Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026)

Elutia (ELUT) reported Total Non-Current Liabilities of $29.3 million for Q1 2026, down 58.75% on a YoY basis from $71.0 million in Q1 2025, and down 7.17% sequentially from $31.6 million in Q4 2025.

Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Elutia (ELUT) has 8 years of Total Non-Current Liabilities data on file, last reported at $29.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities fell 58.75% year-over-year to $29.3 million; the trailing twelve-month figure through Mar 2026 stood at $29.3 million (down 58.75% YoY), and the FY2025 full-year result was $31.6 million, down 52.42% from the prior year.
  • Total Non-Current Liabilities declined to $29.3 million in Q1 2026, from $31.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $104.7 million in Q2 2024 to a low of $29.3 million in Q1 2026.
  • A 5-year average of $66.7 million and a median of $71.0 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities soared 101.78% in 2022 and tumbled 58.75% in 2026, its largest moves.
  • Tracing ELUT's Total Non-Current Liabilities over 5 years: stood at $73.7 million in 2022, then fell by 6.07% to $69.3 million in 2023, then slipped by 4.27% to $66.3 million in 2024, then slumped by 52.42% to $31.6 million in 2025, then retreated by 7.17% to $29.3 million in 2026.
  • Business Quant data shows ELUT's Total Non-Current Liabilities at $29.3 million in Q1 2026, $31.6 million in Q4 2025, and $69.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Elutia 39.99 Mn 11.50 Mn 1.80 Mn 29.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.29 Mn
Dec 31, 2025 31.55 Mn
Sep 30, 2025 69.30 Mn
Jun 30, 2025 66.73 Mn
Mar 31, 2025 71.02 Mn
Dec 31, 2024 66.31 Mn
Sep 30, 2024 82.40 Mn
Jun 30, 2024 104.67 Mn
Mar 31, 2024 78.00 Mn
Dec 31, 2023 69.27 Mn
Sep 30, 2023 83.62 Mn
Jun 30, 2023 74.11 Mn
Mar 31, 2023 72.60 Mn
Dec 31, 2022 73.75 Mn
Sep 30, 2022 71.62 Mn
Jun 30, 2022 53.32 Mn
Mar 31, 2022 36.85 Mn
Dec 31, 2021 52.95 Mn
Sep 30, 2021 35.49 Mn
Jun 30, 2021 38.15 Mn